Residue depletion of florfenicol and its metabolite florfenicol amine in swine tissues after intramuscular administration

Journal of Agricultural and Food Chemistry

Volumn 54, Issue 25, 2006, Pages 9614-9619

  Li, Jiancheng ^a   Ding, Shuangyang ^a   Zhang, Suxia ^a   Li, Cun ^a   Li, Xiaowei ^a   Liu, Zhongwei ^a   Liu, Jinfeng ^a   Shen, Jianzhong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Depletion; Florfenicol; Florfenicol amine; HPLC; Swine tissue

Indexed keywords

ANTIINFECTIVE AGENT; DRUG DERIVATIVE; DRUG RESIDUE; FLORFENICOL; FLORFENICOL AMINE; THIAMPHENICOL; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY; LIVER; METABOLISM; MUSCLE; RANDOMIZED CONTROLLED TRIAL; SWINE;

ANIMALS; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESIDUES; INJECTIONS, INTRAMUSCULAR; KIDNEY; LIVER; MUSCLES; SWINE; THIAMPHENICOL;

ANIMALIA; SUS SCROFA;

EID: 33846166098     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf061869p     Document Type: Article

References (33)

1. Neu, K. P.; Fu, H. C. In vitro activity of chloramphenicol and thiamphenicol analogs. Antimicrob. Agents Chemother. 1980, 18, 311-316.
2. Syriopoulou, V. P.; Harding, A. L.; Gloldmann, D. A.; Smith, A. L. In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob. Agents Chemother. 1981, 19, 294-297.
3. Barigazzi, G.; Candotti, P.; Foni, E. In vitro susceptibility of 108 isolated Actionbacillus pleuropneumoniae strains to 17 antimicrobial agents from pig lungs in Italy in 1994-1995. Proceedings of the 14th International Pig Veterinary Society Congress, Bologna, Italy, 1996; pp 207.
4. Cannon, M.; Harford, S.; Davies, J. Acomparative study on the inhibitory actions of chloramphenicol, thiamphenicol and some fluorinated derivatives. J. Antimicrob. Chemother. 1990, 26, 307-317.
5. Ueda, Y.; Suenaga, I. In vitro antibacterial activity of florfenicol against Actinobacillus pleuropneumoniae. J. Vet. Med. Sci. 1995, 57, 363-364.
6. Samuelsen, O. B.; Bergh, O. Efficacy of orally administered florfenicol and oxolinic acid for the treatment of vibrosis in cod. Aquaculture 2004, 235, 27-35.
7. Hoar, B. R.; Jelinski, M. D.; Ribble, C. S.; Janzen, E. D.; Johnson, J. C. A comparison of the clinical field efficacy and safety of florfenicol and tilmicosin for the treatment of undifferentiated bovine respiratory disease of cattle in western Canada. Can. J. Vet. 1998, 39, 161-166.
8. Shin, S. J.; Kang, S. G.; Nabin, R.; Kang, M. L.; Yoo, H. S. Evaluation of antimicrobial activity of florfenicol against bacteria isolated from bovine and porcine respiratory disease. Vet. Microbiol. 2005, 106, 73-77.
9. Xiao, Z. M. Clinical application and marketed status of florfenicol. J. China Vet. Med. 2000, 34, 53-54.
10. Agricultural Department of P. R. China. 278th Bulletin; Agricultural Department of P. R. China: People's Republic of China, 2003.
11. Committee for Veterinary Medicinal Products (CVMP). The European Agency for the Evaluation of Medicinal Products. Florfenicol (extension to fish), Summary Report, EMEA/MRL/251/97-FINAL, 1997.
12. Committee for Veterinary Medicinal Products (CVMP). The European Agency for the Evaluation of Medicinal Products. Florfenicol (extension to chicken), Summary Report, EMEA/MRL/589/99-FINAL, 1999.
13. Agricultural Department of P. R. China. 235th Bulletin; Agricultural Department of P. R. China: People's Republic of China, 2002.
14. Committee for Veterinary Medicinal Products (CVMP). The European Agency for the Evaluation of Medicinal Products. Florfenicol (extension to pigs), Summary Report, EMEA/MRL/591/99-FINAL, 1999.
15. CFR (Code of Federal Regulations) 556.283, Dec 24, 2002, Washington, DC.
16. Hormazabal, V.; Steffenak, I.; Yndestad, M. Simultaneous determination of residues of florfenicol and the metabolite florfenicol amine in fish tissues by high performance liquid chromatography. J. Chromatogr. 1993, 616, 161-165.
17. Hormazabal, V.; Steffenak, I.; Yndestad, M. Similtaneous extraction and determination of florfenicol and the metabolite florfenicol amine in sediment by high-performance liquid chromatography. J. Chromatogr. A 1996, 724, 364-366.
18. Nagata, T.; Saeki, M. Simultaneous determination of thiamphenicol, florfenicol, and choramphenicol residues in muscles of animals and cultured fish by liquid chromatography. J. Liq. Chromatogr. 1992, 15, 2045-2056.
19. Christopher, L.; Wrzesinsiki, L.; Crouch, S.; Endris, R. Determination of florfenicol amine in channel catfish muscle by liquid chromatography. J. AOAC Int. 2003, 86, 515-520.
20. Jeffery, M.; Riet, V. D.; Potter, R. A.; Christie-Fougere, M.; Burns, B. G. Simultaneous determination of residues of chloramphenicol, thiamphenicol, florfenicol, and florfenicol amine in farmed aquatic species by liquid chromatography/mass spectrometry. J. AOAC Int. 2003, 86, 510-514.
21. Pfenning, A. P.; Roybal, J. E.; Rupp, H. S.; Turnipseed, S. B.; Gonzales, S. A.; Hurlbut, J. A. Simultaneous determination of residues of chloramphenicol, florfenicol, florfenicol amine, and thiamphenicol in shrimp tissue by gas chromatography with electron capture detection. J. AOAC Int. 2000, 83, 26-30.
22. Nagata, T.; Oka, H. Detection of residual chloramphenicol, florfenicol, and thiamphenicol in yellowtail fish muscles by capillary gas chromatography-mass spectrometry. J. Agric. Food Chem. 1996, 44, 1280-1284.
23. Committee for Veterinary Medicinal Products (CVMP). The European Agency for the Evaluation of Medicinal Products. Note for Guidance: Approach Towards Harmonization of Withdrawal Periods, EMEA/CVMP/036/95, 1995.
24. Varma, K. J.; Adams, P. E.; Powers, T. E.; Powers, J. D.; Lamendola, J. F. Pharmacokinetics of florfenicol in veal calves. J. Vet. Pharmacol. Ther. 1986, 9, 412-425.
25. Voorspoels, J.; D'Haese, E.; De Craene, B. A.; Vervaet, C.; De Riemaecker, D.; Deprez, P.; Nelis, H.; Remon, J. P. Pharmacokinetics of florfenicol after treatment of pigs with single oral or intramuscular doses or with medicated feed for three days. Vet. Rec. 1999, 2, 397-399.
26. Liu, J. Z.; Fung, K. F.; Chen, Z. L.; Zhang, J. Tissue pharmacokinetics of florfenicol in pigs experimentally infected with Actinobacillus pleuropneumoniae. Eur. J. Drug Metab. Pharmacokinet. 2002, 27, 265-271.
27. Liu, J. Z.; Fung, K. F.; Chen, Z. L.; Zeng, Z. L.; Zhang, J. Pharmacokinetics of florfenicol in healthy pigs and in pigs experimentally infected with Actinobacillus pleuropneumoniae. Antimicrob. Agents Chemother. 2003, 47, 820-823.
28. Jiang, H. X.; Zeng, Z. L.; Chen, Z. L.; Liu, J. J.; Fung, K. F. Pharmacokinetics of florfenicol in pigs following intravenous, intramuscular or oral administration and the effects of feed intake on oral dosing. J. Vet. Pharmacol. Ther. 2006, 29, 153-156.
29. Afifi, N. A.; El-Sooud, K. A. Tissue concentrations and pharmacokinetics of florfenicol in broiler chickens. Br. Poult. Sci. 1997, 38, 425-428.
30. Lobell, R. D.; Varma, K. J.; Johnson, J. C.; Sams, R. A.; Gerken, D. F.; Ashcraft, S. M. Pharmacokinetics of florfenicol following intravenous and intramuscular dose to cattle. J. Vet. Pharmacol. Ther. 1994, 17, 253-258.
31. Soback, S.; Paape, M. J.; Filep, R. Florfenicol pharmacokinetics in lactating cows after intravenous, intramuscular and intramammary administration. J. Vet. Pharmacol. Ther. 1995, 18, 413-417.
32. Shen, J. Z.; Hu, D. F.; Wu, X. A.; Coats, J. R. Bioavailability and pharmacokinetics of florfenicol in broiler chicken. J. Vet. Pharmacol. Ther. 2003, 26, 337-341.
33. Adams, P. E.; Varma, K. J.; Powers, T. E.; Lamendola, J. F. Tissue concentrations and pharmacokinetics of florfenicol in male veal calves given repeated doses. Am. J. Vet. Res. 1987, 48, 1725-1732.